Papillomas of the breast: factors associated with underestimation

Carregando...
Imagem de Miniatura
Citações na Scopus
16
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Citação
EUROPEAN JOURNAL OF CANCER PREVENTION, v.27, n.4, p.310-314, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The distinction between benign and malignant papilloma of the breast through percutaneous needle biopsy can be difficult because of limited samples; the underestimation rate can be up to 25%. The aim of this study is to identify clinical and histological factors associated with underestimation, invasive ductal carcinoma, or ductal in-situ carcinoma (DCIS) of the breast found in surgical specimens from papillary lesions. This may contribute toward selection of patients for a follow-up strategy without the need for surgical excision. From a database of 3563 patients, we identified 85 with intraductal papilloma between 2007 and 2013 who had undergone breast-imaging studies, percutaneous needle biopsy, and surgical resection of the lesion. Central papillomas normally present with a palpable mass, whereas peripheral papillomas generally do not have clinical manifestations (microcalcifications); both central and peripheral papillomas were related to atypical lesions, 13.5 and 15.4%, respectively. Among the 59 cases of central papillomas, there were four cases of underestimation, three DCIS and one invasive ductal carcinoma (6.8%). Among the 26 cases of peripheral papillomas, there was one case of DCIS (3.8%), with a total underestimation rate of 5.8%; all underestimated lesions measured more than 1cm. The median size was 11mm at mammography and 19mm at ultrasound. Our data suggest that lesions less than 1cm in size, without atypia and concordant imaging and clinical findings, may not require surgical resection.
Palavras-chave
breast cancer, clinical, intraductal papilloma, radiologic
Referências
  1. Ali-Fehmi R, 2003, HUM PATHOL, V34, P234, DOI 10.1053/hupa.2003.25
  2. Cuneo KC, 2012, BREAST J, V18, P475, DOI 10.1111/j.1524-4741.2012.01276.x
  3. Foley NM, 2015, ANN SURG ONCOL, V22, pS385, DOI 10.1245/s10434-015-4773-z
  4. Jacobs TW, 2002, AM J SURG PATHOL, V26, P1095, DOI 10.1097/01.pas.0000024995.88786.11
  5. Jagmohan P, 2013, DIAGN INTERV RADIOL, V19, P471, DOI 10.5152/dir.2013.13041
  6. Kuzmiak CM, 2014, J ULTRAS MED, V33, P1545, DOI 10.7863/ultra.33.9.1545
  7. Lewis JT, 2006, AM J SURG PATHOL, V30, P665, DOI 10.1097/00000478-200606000-00001
  8. Lu QH, 2012, ANZ J SURG, V82, P168, DOI 10.1111/j.1445-2197.2011.05969.x
  9. Mosier AD, 2013, BREAST J, V19, P611, DOI 10.1111/tbj.12180
  10. OHUCHI N, 1984, CANCER, V54, P605, DOI 10.1002/1097-0142(1984)54:4<605::AID-CNCR2820540402>3.0.CO;2-6
  11. Provencher L, 2012, RADIOLOGY, V263, P43, DOI 10.1148/radiol.11111293
  12. Rageth CJ, 2016, BREAST CANCER RES TR, V159, P203, DOI 10.1007/s10549-016-3935-4
  13. Renshaw AA, 2004, AM J CLIN PATHOL, V122, P217, DOI 10.1309/K1BNJXETEY3H06UL
  14. Richter-Ehrenstein C, 2011, BREAST, V20, P501, DOI 10.1016/j.breast.2011.05.004
  15. Swapp RE, 2013, ANN SURG ONCOL, V20, P1900, DOI 10.1245/s10434-012-2846-9
  16. Tatarian T, 2016, ANN SURG ONCOL, V23, P2501, DOI 10.1245/s10434-016-5182-7
  17. Ueng SH, 2009, ARCH PATHOL LAB MED, V133, P893, DOI 10.1043/1543-2165-133.6.893
  18. Yi WJ, 2013, WORLD J SURG, V37, P2613, DOI 10.1007/s00268-013-2178-3